Want to see JP:8095 full AI Analyst Report?
Top Page
Astena Holdings Co.,Ltd.
(8095)
Select Model
Select Model
Rating:63Neutral
Price Target:
¥548.00
▲(13.46% Upside)
Action:Reiterated
Date:08/06/26
The score is driven by attractive valuation (low P/E and solid dividend yield) and a constructive price trend above key moving averages. These positives are tempered by middling financial performance, primarily due to volatile earnings and inconsistent/weak free cash flow generation.
Positive Factors
Improving Gross Margins
Sustained expansion of gross margin reflects structural improvement in cost base or product mix. Higher gross margins enhance operating leverage, improve resilience to input-cost shocks, and create durable capacity to fund R&D, dividends, or debt reduction over coming quarters.
Negative Factors
Earnings Volatility
Pronounced swings in net income undermine predictability for capital allocation, dividend coverage, and investment planning. Persistent volatility raises the likelihood that earnings can revert, constraining strategic decisions and increasing the premium required by creditors and partners.
Read all positive and negative factors
Positive Factors
Negative Factors
Improving Gross Margins
Sustained expansion of gross margin reflects structural improvement in cost base or product mix. Higher gross margins enhance operating leverage, improve resilience to input-cost shocks, and create durable capacity to fund R&D, dividends, or debt reduction over coming quarters.
Read all positive factors
Astena Holdings Co.,Ltd. (8095) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥21.99B
Dividend Yield3.33%
Average Volume (3M)270.46K
Price to Earnings (P/E)9.4
Beta (1Y)0.64
Revenue Growth12.01%
EPS GrowthN/A
CountryJP
Employees1,543
SectorIndustrials
Sector Strength72
IndustryMedical - Pharmaceuticals
Share Statistics
EPS (TTM)54.24
Shares Outstanding41,182,423
10 Day Avg. Volume280,330
30 Day Avg. Volume270,463
Financial Highlights & Ratios
PEG Ratio-0.05
Price to Book (P/B)0.70
Price to Sales (P/S)0.30
P/FCF Ratio37.67
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Astena Holdings Co.,Ltd. Business Overview & Revenue Model
Company Description
Astena Holdings Co., Ltd., a Japanese company founded in 1914 and based in Chuo, is engaged in the development and distribution of a wide array of healthcare and chemical products. Its Fine Chemical division specializes in manufacturing and sellin...
How the Company Makes Money
null...
Astena Holdings Co.,Ltd. Financial Statement Overview
Summary
Income Statement
63
Positive
Balance Sheet
56
Neutral
Cash Flow
42
Neutral
| Breakdown | Nov 2025 | Nov 2024 | Nov 2023 | Nov 2022 | Nov 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 62.74B | 57.99B | 51.98B | 49.64B | 72.32B |
| Gross Profit | 21.87B | 19.37B | 16.32B | 15.44B | 16.60B |
| EBITDA | 5.51B | 849.75M | 4.17B | 3.90B | 5.21B |
| Net Income | 2.19B | -2.53B | 1.16B | 579.60M | 1.74B |
Balance Sheet | |||||
| Total Assets | 75.44B | 64.60B | 67.25B | 63.55B | 63.55B |
| Cash, Cash Equivalents and Short-Term Investments | 10.19B | 6.10B | 6.88B | 6.93B | 10.93B |
| Total Debt | 22.65B | 14.99B | 16.99B | 15.05B | 15.16B |
| Total Liabilities | 48.04B | 39.29B | 38.65B | 36.48B | 36.55B |
| Stockholders Equity | 27.08B | 25.17B | 28.42B | 26.99B | 27.00B |
Cash Flow | |||||
| Free Cash Flow | 500.00M | 1.65B | -2.52B | -3.77B | -2.14B |
| Operating Cash Flow | 3.39B | 4.85B | 1.64B | -742.42M | 1.35B |
| Investing Cash Flow | -5.55B | -2.94B | -2.83B | -2.22B | -4.38B |
| Financing Cash Flow | 6.19B | -2.65B | 1.08B | -1.09B | 6.35B |
Astena Holdings Co.,Ltd. Technical Analysis
Positive
483.00
Price Trends
515.68
Positive
497.10
Positive
482.80
Positive
Market Momentum
8.02
Negative
69.80
Neutral
73.41
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:8095, the sentiment is Positive. The current price of 483 is below the 20-day moving average (MA) of 525.60, below the 50-day MA of 515.68, and above the 200-day MA of 482.80, indicating a bullish trend. The MACD of 8.02 indicates Negative momentum. The RSI at 69.80 is Neutral, neither overbought nor oversold. The STOCH value of 73.41 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:8095.
Astena Holdings Co.,Ltd. Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥21.99B | 9.41 | ― | 3.73% | 12.01% | ― | |
59 Neutral | ¥5.89B | 49.80 | ― | 2.65% | 9.45% | ― | |
55 Neutral | ¥15.21B | 16.84 | ― | 2.32% | 8.19% | -25.81% | |
55 Neutral | ¥7.43B | -10.78 | ― | ― | -71.21% | -485.42% | |
52 Neutral | ¥14.14B | 19.27 | ― | 1.83% | 2.87% | -73.55% | |
38 Underperform | ¥5.72B | -3.59 | ― | ― | ― | 33.26% |
* Industrials Sector Average
JP:8095
Astena Holdings Co.,Ltd.
540.00
42.11
8.46%
JP:2796
Pharmarise Holdings Corp.
500.00
13.11
2.69%
JP:3417
Ohki Health Care Holdings, Inc.
1,058.00
-265.85
-20.08%
JP:4350
Medical System Network Co., Ltd.
500.00
37.97
8.22%
JP:4890
Tsubota Laboratory Incorporated
290.00
-77.00
-20.98%
JP:190A
Chordia Therapeutics Inc.
72.00
-105.00
-59.32%
Astena Holdings Co.,Ltd. Corporate Events
Astena Holdings Secures ¥4.3 Billion Loan With Covenants to Fund Ikeda Industries Acquisition
Aug 4, 2026
Astena Holdings Co., Ltd. has disclosed that it entered into a monetary loan agreement in December 2025 to finance its subsidiary IWAKI CO., LTD.’s acquisition of Ikeda Industries Corporation, with funds drawn down later that month. The loan...
Astena Holdings Confirms Special Account Settlement and Maintains Stable Dividend Policy
Jul 31, 2026
Astena Holdings Co., Ltd., a TSE Prime Market-listed diversified group, manages shareholder returns under a stable, performance-linked dividend framework targeting a minimum DOE of 1.5% and a payout ratio of about 30%. Guided by its Astena 2030 &#...
Astena Holdings Beats H1 Forecasts on AI-Driven Chemical Demand
Jul 13, 2026
Astena Holdings reported that its results for the six months ended May 31, 2026 exceeded earlier forecasts, with net sales of ¥34.57 billion and profits significantly above guidance. Operating profit rose to ¥2.29 billion versus a ¥...
Astena Holdings Posts Higher First-Half Earnings and Confirms Dividend and Full-Year Outlook
Jul 13, 2026
Astena Holdings reported consolidated net sales of ¥34.566 billion for the six months ended May 31, 2026, up 14.8% year on year, with operating profit rising 3.2% to ¥2.294 billion and profit attributable to owners of parent increasing 1...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.